|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Intangible asset amortization | |||||
| Depreciation and amortization expense | |||||
| Depreciation and amortization | |||||
| Goodwill impairment expense | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other expenses: | |||||
| Interest expense | |||||
| Net other income (expense) | |||||
| Net other income | |||||
| Total other expenses | |||||
| Income (loss) before income taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net loss | |||||
| Other comprehensive income (loss) | |||||
| Foreign currency translation adjustment, net of tax of $6, $(956), $(717) | |||||
| Reclassification of fair value of interest rate swap, net of tax of $0, $0, $(765) | |||||
| Change in fair value of interest rate swap, net of tax of $253, $$(827), $1,393 | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per share attributable to common stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...